[Cardiovascular diseases and clinical laboratory examination. (4). Metabolic abnormalities in hypertension and their modification by antihypertensive drugs].
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002118:Calcium / Q000097:blood; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002784:Cholesterol / Q000097:blood*; D004232:Diuretics / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012306:Risk; D014280:Triglycerides / Q000097:blood*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D014280:Triglycerides; D002784:Cholesterol; D002118:Calcium